Kinetics of early immune reconstitution and its exploratory association with post-transplant outcomes in patients undergoing haploidentical HCT with post-transplant cyclophosphamide-based GvHD prophylaxis
Post-transplant cyclophosphamide (PTCy) is widely used for graft-versus-host disease (GvHD) prophylaxis in haploidentical hematopoietic cell transplantation. However, the kinetics of early immune reconstitution in real-world, heterogeneous cohorts, and their relationship with early outcomes, remain incompletely def...